262 related articles for article (PubMed ID: 16009905)
21. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.
Sakurai T
Nat Rev Neurosci; 2007 Mar; 8(3):171-81. PubMed ID: 17299454
[TBL] [Abstract][Full Text] [Related]
22. Galanin-like peptide promotes feeding behaviour via activation of orexinergic neurones in the rat lateral hypothalamus.
Kageyama H; Kita T; Toshinai K; Guan JL; Date Y; Takenoya F; Kato S; Matsumoto H; Ohtaki T; Nakazato M; Shioda S
J Neuroendocrinol; 2006 Jan; 18(1):33-41. PubMed ID: 16451218
[TBL] [Abstract][Full Text] [Related]
23. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
[TBL] [Abstract][Full Text] [Related]
25. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
Cortese S; Konofal E; Lecendreux M
Med Hypotheses; 2008 Nov; 71(5):770-5. PubMed ID: 18678446
[TBL] [Abstract][Full Text] [Related]
26. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
Takahashi K; Lin JS; Sakai K
Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
[TBL] [Abstract][Full Text] [Related]
27. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
28. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.
Sakurai T; Nagata R; Yamanaka A; Kawamura H; Tsujino N; Muraki Y; Kageyama H; Kunita S; Takahashi S; Goto K; Koyama Y; Shioda S; Yanagisawa M
Neuron; 2005 Apr; 46(2):297-308. PubMed ID: 15848807
[TBL] [Abstract][Full Text] [Related]
29. Non-sleep effects of hypocretin/orexin.
Samson WK; Taylor MM; Ferguson AV
Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
[TBL] [Abstract][Full Text] [Related]
30. Hypocretin-1 deficiency in a girl with ROHHAD syndrome.
Dhondt K; Verloo P; Verhelst H; Van Coster R; Overeem S
Pediatrics; 2013 Sep; 132(3):e788-92. PubMed ID: 23940246
[TBL] [Abstract][Full Text] [Related]
31. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K; Sakurai T
Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
[TBL] [Abstract][Full Text] [Related]
32. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
[TBL] [Abstract][Full Text] [Related]
33. Cortical excitability changes in patients with sleep-wake disturbances after traumatic brain injury.
Nardone R; Bergmann J; Kunz A; Caleri F; Seidl M; Tezzon F; Gerstenbrand F; Trinka E; Golaszewski S
J Neurotrauma; 2011 Jul; 28(7):1165-71. PubMed ID: 21446790
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
35. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
36. Involvement of hypocretin neurons in multiple system atrophy.
Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
Acta Neuropathol; 2007 Jan; 113(1):75-80. PubMed ID: 17089135
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of orexin/hypocretin-like immunoreactive peptides and melanin-concentrating hormone in the brain and pituitary of medaka.
Amiya N; Amano M; Oka Y; Iigo M; Takahashi A; Yamamori K
Neurosci Lett; 2007 Oct; 427(1):16-21. PubMed ID: 17935885
[TBL] [Abstract][Full Text] [Related]
38. Distribution of orexin/hypocretin immunoreactivity in the brain of a male songbird, the house finch, Carpodacus mexicanus.
Singletary KG; Deviche P; Strand C; Delville Y
J Chem Neuroanat; 2006 Dec; 32(2-4):81-9. PubMed ID: 16806811
[TBL] [Abstract][Full Text] [Related]
39. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
[TBL] [Abstract][Full Text] [Related]
40. Posterior hypothalamus and regulation of vigilance states.
Goutagny R; Verret L; Fort P; Salvert D; Léger L; Luppi PH; Peyron C
Arch Ital Biol; 2004 Jul; 142(4):487-500. PubMed ID: 15493550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
